VIRS
Pacer BioThreat Strategy ETF
VIRS
VIRS
Delisted
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $2.32M invested in Pacer BioThreat Strategy ETF in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$494K |
Top Sellers
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$206K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$22.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$52 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Osaic Holdings
Scottsdale,
Arizona
| $1.6M | -$22.6K | -849 | -1% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $712K | +$494K | +18,577 | +227% |
|
|
3
UBS Group
Zurich,
Switzerland
| $12K | -$52 | -2 | -0.4% |
|
|
4
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$206K | -6,655 | Closed |
|